LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19

BACKGROUND: Vaccination strategies that provide enhanced immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are needed. We evaluated the safety and immunogenicity of a bivalent omicron containing vaccine, mRNA-1273.214 (50 µg), administered as a second booster dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalkias, Spyros, Harper, Charles, Vrbicky, Keith, Walsh, Stephen R, Essink, Brandon, Brosz, Adam, McGhee, Nichole, Tomassini, Joanne, Chen, Xing, Chang, Ying, Sutherland, Andrea, Montefiori, David, Girard, Bethany, Edwards, Darin, Feng, Jing, Zhou, Honghong, Baden, Lindsey R, Miller, Jacqueline, Das, Rituparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752807/
http://dx.doi.org/10.1093/ofid/ofac492.1873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752807/
http://dx.doi.org/10.1093/ofid/ofac492.1873

Ejemplares similares